Adma Biologics (ADMA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
Go back to Adma Biologics (ADMA) Tops Q1 EPS by 1c
May 12, 2015 4:44 PM EDT
RAMSEY, N.J., May 12, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced its financial results for the first quarter ended March 31, 2015, in addition to providing a corporate update and anticipated milestones for 2015.
"ADMA continued to execute against expected milestones for the first quarter 2015," stated Adam Grossman, President and CEO of ADMA Biologics. "We announced positive primary and secondary endpoint data at two medical conferences generated from our... More
May 12, 2015 4:44 PM EDT
RAMSEY, N.J., May 12, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced its financial results for the first quarter ended March 31, 2015, in addition to providing a corporate update and anticipated milestones for 2015.
"ADMA continued to execute against expected milestones for the first quarter 2015," stated Adam Grossman, President and CEO of ADMA Biologics. "We announced positive primary and secondary endpoint data at two medical conferences generated from our... More
